In this context, the groups of Beck-Sickinger88 and Hey-Hawkins89, 90, 91 reported that the combination of carborane and hY1R, GRPR, or GhrR could represent a boron delivery agent in BNCT for the delivery of therapeutic drugs to cancer cells. This evidence concerns the gene GRPR and cancer.